Document is current
Any future updates will be listed below
-
Authors
Pils, Marlene
Dybala, Alexandra
Schaffrath, Anja
Rehn, Fabian
Kutzsche, Janine
Blömeke, Lara
Tusche, Markus
Özdüzenciler, Pelin
Bujnicki, Tuyen
Kraemer-Schulien, Victoria
Gramespacher, Hannes
Schmieschek, Maximilian H.T.
Barbe, Michael T.
Onur, Oezguer A.
Fink, Gereon R.
Tamgüney, Gültekin
Bannach, Oliver
Willbold, Dieter
-
Funding
Funding for this research was provided by:
Heinrich-Heine-Universität Düsseldorf
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 5 October 2024
First Online: 14 October 2024
Declarations
:
: The study was approved by the local ethics committee (Ethics Commission of the Faculty of Medicine of the University of Cologne, approval number 19-1644) and carried out in accordance with the Declaration of Helsinki and its later amendments. All participants agreed to be a participant in this study and gave their written informed consent to participate. All participants were aware of what this study involves, that each participant was at least 18 years old, and have received a copy of this informed consent.
: No identifying information about participants is available in the article.
: D.W. and O.B. are cofounders and shareholders of attyloid GmbH. D.W. is member of attyloid’s supervisory board. M.P., O.B., G.T. and D.W. are inventors of patent DE102020114278A1 (determination of disease-specific protein aggregates in fecal samples). These factors did not influence the interpretation of the data. Remaining authors declare no conflicts of interest.
